Clinical Trials Browser

Phase 2 × INDUSTRY × Interferons × Clear all

NCT00117637 2014-10-31

BAY43-9006 (Sorafenib) Versus Interferon Alpha-2a in Patients With Unresectable and/or Metastatic Renal Cell Carcinoma

Phase 2 Completed

189 enrolled 44 charts

Carcinoma, Renal Cell, Neoplasms